Business Context and Reporting Period
This Form 6-K filing serves as the Notice of Annual General Meeting and Proxy Statement for Amdocs Limited, a foreign private issuer organized under the laws of Guernsey. The filing was issued on December 23, 2024, for a shareholder meeting scheduled for January 31, 2025. The record date for shareholders entitled to vote was December 3, 2024, with 112,819,363 ordinary shares outstanding. The filing seeks shareholder approval for five specific proposals regarding governance, compensation, dividends, and financial statements for the fiscal year ended September 30, 2024.
Key Financial Metrics and Capital Allocation
While this filing does not contain a full income statement, it provides specific data points regarding capital allocation and equity plans:
- Dividend Proposal: The Board proposes increasing the quarterly cash dividend from $0.479 to $0.527 per share, effective April 2025 pending approval.
- Share Repurchases: The company repurchased approximately $563.1 million of its ordinary shares during the fiscal year ended September 30, 2024. Repurchases were $489.5 million in FY2023 and $508.5 million in FY2022.
- Equity Compensation: As of December 3, 2024, the 1998 Stock Option and Incentive Plan had 4,797,226 shares available for future awards. The weighted average exercise price of outstanding options was $66.02.
- Director Compensation: Non-employee directors receive an annual cash retainer of $80,000 plus an annual equity grant valued at $255,000. The Chairman receives an additional $200,000 in equity.
- Auditor Fees: Total fees billed by Ernst & Young LLP for fiscal year 2024 were $5.9 million ($3.7M audit, $1.4M audit-related, $0.8M tax).
Material Changes and Proposals
The filing outlines five material actions requiring shareholder approval:
- Election of Directors: Re-election of nine incumbent directors, including CEO Shuky Sheffer and Chairman Eli Gelman. A waiver was granted for director Rafael de la Vega to serve past the mandatory retirement age of 73 until 2026.
- Extension of Equity Plan: Extension of the term of the 1998 Stock Option and Incentive Plan to January 31, 2035. No new shares are being added to the plan; the extension ensures the company can continue granting equity awards.
- Dividend Increase: Approval to raise the quarterly dividend rate by approximately 10% (from $0.479 to $0.527).
- Financial Statements: Approval of the Consolidated Financial Statements for the fiscal year ended September 30, 2024.
- Auditor Ratification: Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending September 30, 2025.
Outlook, Risks, and Management Commentary
Capital Return Strategy: Management stated a long-term guideline to return a majority of free cash flow to shareholders through dividends and share repurchases, subject to financial performance, liquidity, and potential M&A activity. The dividend increase is justified by historical growth in revenue, net income, and free cash flow since 2012.
Risk Management: The Board oversees risk management, with the Audit Committee specifically reviewing enterprise risk management policies. The company maintains a clawback policy for executive compensation and enforces stock ownership guidelines (e.g., CEO required to hold 6x annual base salary).
Contingencies: If the dividend increase is not approved, the rate will remain at $0.479. If the equity plan extension is not approved, the company will not be able to grant awards under the 1998 Plan after January 28, 2025, and the Board will evaluate alternatives.
Investor Verification Checklist
- Verify the Consolidated Financial Statements for the fiscal year ended September 30, 2024, in the Annual Report on Form 20-F to confirm the revenue and net income growth cited as justification for the dividend increase.
- Review the Free Cash Flow calculation methodology to assess the sustainability of the proposed dividend increase and continued share repurchases.
- Confirm the Equity Burn Rate (1.21% in FY2024) to evaluate the dilution impact of the extended 1998 Stock Option Plan.
- Check the Share Repurchase activity in the most recent quarterly filings to see if the $563.1 million annual figure aligns with current cash flow trends.
- Review the Director Independence disclosures, specifically regarding the waiver granted to Rafael de la Vega to serve past age 73.